Product
Dupixent®
2 clinical trials
3 indications
Indication
Atopic DermatitisIndication
Allergic RhinoconjunctivitisIndication
Seasonal Allergic RhinitisClinical trial
A Randomized, Double-blinded, Active Comparator-controlled, 16-week, Single-site, Exploratory, Mechanistic Trial to Assess the Effect of LEO 138559 on the Molecular Signature and Safety in Adults With Moderate to Severe Atopic Dermatitis.Status: Completed, Estimated PCD: 2023-06-07
Clinical trial
Grass Pollen Sublingual Tablet Immunotherapy Plus Dupilumab for Induction of Tolerance in Adults With Moderate to Severe Seasonal Allergic Rhinitis (ITN084AD)Status: Active (not recruiting), Estimated PCD: 2025-01-01